phosphatidylcholines has been researched along with methylnaltrexone in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (methylnaltrexone) | Trials (methylnaltrexone) | Recent Studies (post-2010) (methylnaltrexone) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 320 | 56 | 133 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, M; Lin, DH; McEntee, E; Qin, LF; Wang, CZ; Wang, JT; Xie, XX; Yuan, CS | 1 |
1 other study(ies) available for phosphatidylcholines and methylnaltrexone
| Article | Year |
|---|---|
Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Gastrointestinal Tract; Male; Naltrexone; Narcotic Antagonists; Phosphatidylcholines; Quaternary Ammonium Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; X-Ray Diffraction | 2014 |